Kategorien
-
Adhesives
6
Amines
98
Amino Acids
184
Analytical Reagents
701
Antibiotics
254
Bioactive Small Molecules
735
Aroma Chemicals
212
Biochemicals
1040
Boronic Acids
4
Buffers
97
Building Blocks
1901
Carbohydrates
179
Catalysts
108
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
261
Flavours and Fragrance Materials
212
Fluorinated Products
50
Furans
6
Gases in Solution
48
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
341
Ion-Pair Reagents
23
Ligands
80
Organics
1417
Oxazoles
3
Peptide Reagents
90
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
105
Research Organics & Inorganics
790
Salts
296
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
301
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
49
Water Analysis
12
N-1-[3,5-di(tert-butyl)-2-hydroxybenzylidine]-pyridine-2-carboxamidrazone
(90026479 | 877928-72-8)
CAS: | 877928-72-8 |
---|---|
Molekularformel: | C21H28N4O |
Molekulargewicht: | 352.47 |
Verfügbarkeit: | Bitte kontaktieren Sie uns |
---|---|
Downloads: | | |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
90026479-1g | 1g | £140.00 | |
Bulk Menge |
90026479-1g | 1g | €196.00 | |
Bulk Menge |
90026479-1g | 1g | $210.00 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 90026479 | ||||
Product Name | N-1-[3,5-di(tert-butyl)-2-hydroxybenzylidine]-pyridine-2-carboxamidrazone | ||||
Categories | Building Blocks Organics | ||||
CAS | 877928-72-8 | ||||
Molecular Formula | C21H28N4O | ||||
Molecular Weight | 352.47 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2933399990 |
Produktspezifikation
Solubility | Complete solution, may contain haziness | ||||
Appearance | Lemon yellow powder | ||||
1H-NMR | Consistent with structure |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|